Brookfield Corp’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-97,854
Closed -$1.22M 377
2023
Q2
$1.22M Sell
97,854
-61,191
-38% -$826K ﹤0.01% 452
2023
Q1
$2.23M Buy
159,045
+72,966
+85% +$1.05M 0.01% 409
2022
Q4
$1.23M Sell
86,079
-388,243
-82% -$6.11M ﹤0.01% 479
2022
Q3
$12.1M Buy
474,322
+16,682
+4% +$419K 0.04% 143
2022
Q2
$13M Buy
457,640
+397,640
+663% +$12.6M 0.06% 119
2022
Q1
$2.12M Buy
60,000
+29,098
+94% +$975K 0.01% 387
2021
Q4
$1.29M Sell
30,902
-15,559
-33% -$630K 0.01% 401
2021
Q3
$2.28M Buy
+46,461
New +$2.27M 0.01% 327

Other funds holding MRVI